Status:
ENROLLING_BY_INVITATION
Enterprise 2 Vascular Reconstruction Device
Lead Sponsor:
Methodist Health System
Conditions:
Aneurysm
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to collect data regarding the effectiveness of using the Enterprise 2 Reconstruction Device in successfully embolizing intracranial aneurysms with wide neck conf...
Detailed Description
The Codman Enterprise 2 Vascular Reconstruction Device is a self-expanding nitinol, compliant, closed-cell, recapturable design that can be deployed by a single operator. The Codman Enterprise 2 Vascu...
Eligibility Criteria
Inclusion
- Adult patients (18 years old or older) with intracranial aneurysms with a wide neck (defined as \> or = to 4mm, or with a dome to neck ratio of 2:1 or greater).
Exclusion
- Small-necked aneurysms, inappropriate for stenting.
- Inability to tolerate anti-platelet medication.
Key Trial Info
Start Date :
February 28 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05254067
Start Date
February 28 2017
End Date
February 1 2025
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moody Brain and Spine Institute at Methodist Dallas Medical Center
Dallas, Texas, United States, 75203